The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 13, 2022
Filed:
Jun. 19, 2017
Applicants:
Istituto Europeo Di Oncologia (Ieo), Milan, IT;
Fondazione Istituto Firc Di Oncologia Molecolare (Ifom), Milan, IT;
Universita Degli Studi Di Milano (University of Milan), Milan, IT;
Inventors:
Pier Paolo Di Fiore, Milan, IT;
Salvatore Pece, Milan, IT;
Manuela Vecchi, Milan, IT;
Stefano Confalonieri, Milan, IT;
Assignees:
Istituto Europeo di Oncologia S.r.l., Milan, IT;
Fondazione Istituto Firc di Oncologia Molecolare (IFOM), Milan, IT;
University of Milan, Milan, IT;
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/68 (2018.01); C12P 19/34 (2006.01); C12Q 1/6886 (2018.01); G16B 5/00 (2019.01); G16B 40/00 (2019.01);
U.S. Cl.
CPC ...
C12Q 1/6886 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/112 (2013.01); C12Q 2600/118 (2013.01); C12Q 2600/158 (2013.01); C12Q 2600/16 (2013.01); C12Q 2600/166 (2013.01); G16B 5/00 (2019.02); G16B 40/00 (2019.02);
Abstract
The present invention relates to refined prognostic clinical tools, methods, and kits for the evaluation of risk and treatment of distant recurrence in ER+/HER2− breast cancer patients.